İmmünsüpresanlar

Martin ED, Berg T, Berenguer M, et al. EASL Clinical Practice Guidelines on liver transplantation. J Hepatol. 2024;81(6):1040-1086. doi:10.1016/j.jhep.2024.07.032

Robinson MW, Harmon C, O’Farrelly C. Liver immunology and its role in inflammation and homeostasis. Cell Mol Immunol. 2016;13(3):267-276. doi:10.1038/cmi.2016.3

Nedredal GI, Picon RV, Chedid MF, Foss A. Immunosuppression in Liver Transplantation: State of the Art and Future Perspectives. http://www.eurekaselect.com. Accessed January 12, 2025. https://www.eurekaselect.com/article/107252

Di Maira T, Little EC, Berenguer M. Immunosuppression in liver transplant. Best Pract Res Clin Gastroenterol. 2020;46-47:101681. doi:10.1016/j.bpg.2020.101681

Halliday N, Westbrook RH. Liver transplantation: post-transplant management. Br J Hosp Med. 2017;78(5):278-285. doi:10.12968/hmed.2017.78.5.278

John M Vierling, MD, FACP, FAASLD, AGAFDanielle Brandman, MD, MAS. Liver transplantation in adults: Initial and maintenance immunosuppression. https://www.uptodate.com/contents/liver-transplantation-in-adults-initial-and-maintenance-immunosuppression

Montano-Loza AJ, Rodríguez-Perálvarez ML, Pageaux GP, Sanchez-Fueyo A, Feng S. Liver transplantation immunology: Immunosuppression, rejection, and immunomodulation. J Hepatol. 2023;78(6):1199-1215. doi:10.1016/j.jhep.2023.01.030

Cotter TG, Rinella M. Nonalcoholic Fatty Liver Disease 2020: The State of the Disease. Gastroenterology. 2020;158(7):1851-1864. doi:10.1053/j.gastro.2020.01.052

Liu CL, Fan ST, Lo CM, et al. Interleukin-2 receptor antibody (basiliximab) for immunosuppressive induction therapy after liver transplantation: a protocol with early elimination of steroids and reduction of tacrolimus dosage. Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc. 2004;10(6):728-733. doi:10.1002/lt.20144

Bhat M, Ghali P, Wong P, et al. Immunosuppression with budesonide for liver transplant recipients with severe infections. Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc. 2012;18(2):262-263. doi:10.1002/lt.22453

Muduma G, Saunders R, Odeyemi I, Pollock RF. Systematic Review and Meta-Analysis of Tacrolimus versus Ciclosporin as Primary Immunosuppression After Liver Transplant. PloS One. 2016;11(11):e0160421. doi:10.1371/journal.pone.0160421

Neuberger JM, Bechstein WO, Kuypers DRJ, et al. Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients: A Guidance Report and Clinical Checklist by the Consensus on Managing Modifiable Risk in Transplantation (COMMIT) Group. Transplantation. 2017;101(4S):S1. doi:10.1097/TP.0000000000001651

Shuker N, van Gelder T, Hesselink DA. Intra-patient variability in tacrolimus exposure: Causes, consequences for clinical management. Transplant Rev. 2015;29(2):78-84. doi:10.1016/j.trre.2015.01.002

Haddad EM, McAlister VC, Renouf E, Malthaner R, Kjaer MS, Gluud LL. Cyclosporin versus tacrolimus for liver transplanted patients. Cochrane Database Syst Rev. 2006;2006(4):CD005161. doi:10.1002/14651858.CD005161.pub2

Saliba F, Dharancy S, Salamé E, et al. Time to Conversion to an Everolimus-Based Regimen: Renal Outcomes in Liver Transplant Recipients From the EVEROLIVER Registry. Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc. 2020;26(11):1465-1476. doi:10.1002/lt.25879

Boudjema K, Camus C, Saliba F, et al. Reduced-dose tacrolimus with mycophenolate mofetil vs. standard-dose tacrolimus in liver transplantation: a randomized study. Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg. 2011;11(5):965-976. doi:10.1111/j.1600-6143.2011.03486.x

Grigg SE, Sarri GL, Gow PJ, Yeomans ND. Systematic review with meta-analysis: sirolimus- or everolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma. Aliment Pharmacol Ther. 2019;49(10):1260-1273. doi:10.1111/apt.15253

Millson C, Considine A, Cramp ME, et al. Adult liver transplantation: UK clinical guideline - part 2: surgery and post-operation. Frontline Gastroenterol. 2020;11(5):385-396. doi:10.1136/flgastro-2019-101216

De Martin E, Londoño MC, Emamaullee J, et al. The optimal immunosuppression management to prevent early rejection after liver transplantation: A systematic review of the literature and expert panel recommendations. Clin Transplant. 2022;36(10):e14614. doi:10.1111/ctr.14614

Poudel S, Gupta S, Saigal S. Basics and Art of Immunosuppression in Liver Transplantation. J Clin Exp Hepatol. 2024;14(3). doi:10.1016/j.jceh.2024.101345